T2D: Don't Sugar Coat It

Understanding Insufficient GLP-1 Activity in T2D



What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

This podcast is sponsored by Novo Nordisk and is intended for clinicians.


John E. Anderson, MD, is an internal medicine and diabetes specialist at The Frist Clinic in Nashville, Tennessee.

Javier Morales, MD, FACP, FACE, specializes in Internal Medicine, Diabetes, and Primary Care and is an associate clinical professor at Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine on Long Island, New York.

Richard E. Pratley, MD, specializes in Internal Medicine and Diabetes at the AdventHealth Diabetes Institute in Orlando, Florida.

Submit Feedback